Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
| ▸ | APEX1 | P27695 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | PPARD | Q03181 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1532120 | 0.95 | PPARG (0.46) | PPARGALDH1A1CYP1A2CYP2C9CA12 | |
| SCHEMBL26480 | 0.94 | PPARG (0.45) | PPARGALDH1A1CYP1A2CYP2C9CA12 | |
| SCHEMBL1532004 | 0.94 | PPARG (0.45) | PPARGALDH1A1CYP1A2CYP2C9CA12 | |
| SCHEMBL8980779 | 0.90 | ALDH1A1 (0.50) | PPARGALDH1A1CYP1A2CYP2C9CA12 | |
| SCHEMBL4339878 | 0.87 | PPARG (0.40) | PPARGALDH1A1CYP1A2CYP2C9CA12 | |
| SCHEMBL18262805 | 0.84 | GAA (0.59) | PPARGALDH1A1CYP1A2CYP2C9CA12 | |
| Hexanoate SCHEMBL27567437 | 0.80 | AKR1B1 (0.48) | PPARGALDH1A1CYP1A2CYP2C9HSD17B10 | |
| SCHEMBL14690385 | 0.79 | ALDH1A1 (0.40) | ALDH1A1CYP1A2CYP2C9CA12CA9 | |
| SCHEMBL2558508 | 0.79 | ALDH1A1 (0.40) | ALDH1A1CYP1A2CYP2C9CA12CA9 | |
| SCHEMBL16456622 | 0.78 | ASAH1 (0.44) | ALDH1A1KDM4EPOLBHSD17B10SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2021449-B1 | ENCAPSULATED BLEACHING AGENT PARTICLES | HENKEL AG & CO KGAA (DE) | 2013-01-16 | — | — | EP | claimed |
| US-7897557-B2 | Encapsulated bleaching agent particles | HENKEL AG & CO. KGAA (DE) | 2011-03-01 | — | — | US | claimed |
| US-20090075856-A1 | Encapsulated Bleaching Agent Particles | HENKEL AG & CO. KGAA (DE) | 2009-03-19 | — | — | US | claimed |
| US-20070093402-A1 | Bleaching agent particles encapsulated in a water soluble material | HENKEL AG & CO. KGAA (DE) | 2007-04-26 | — | — | US | claimed |
| US-10093621-B2 | 4-oxo-N-(4-hydroxyphenyl)retinamide derivatives as therapeutic agents for the treatment of cancer | FONDAZIONE IRCCS INSTITUTO NAZIONALE DEI TUMORI (IT) | 2018-10-09 | — | — | US | disclosed |
| EP-3194360-B1 | 4-OXO-N-(4-HYDROXYPHENYL)RETINAMIDE DERIVATIVES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER | FONDAZIONE IRCCS ISTITUTO NAZ DEI TUMORI (IT) | 2018-06-27 | — | — | EP | disclosed |
| US-20170253560-A1 | 4-OXO-N-(4-HYDROXYPHENYL)RETINAMIDE DERIVATIVES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER | FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI (IT) | 2017-09-07 | — | — | US | disclosed |
| EP-3194360-A1 | 4-OXO-N-(4-HYDROXYPHENYL)RETINAMIDE DERIVATIVES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER | Fondazione IRCCS Istituto Nazionale dei Tumori (IT) | 2017-07-26 | — | — | EP | disclosed |
| WO-2016042010-A1 | 4-OXO-N-(4-HYDROXYPHENYL)RETINAMIDE DERIVATIVES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER | FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI (IT) | 2016-03-24 | — | — | WO | disclosed |
| US-20140171328-A1 | NOVEL COMPOSITE | REVOLYMER (U.K.) LIMITED (GB) | 2014-06-19 | — | — | US | disclosed |
| US-20140171327-A1 | NOVEL COMPOSITE | REVOLYMER (U.K.) LIMITED (GB) | 2014-06-19 | — | — | US | disclosed |
| EP-2697355-A1 | PARTICLES WITH HYDROXYL VINYLIC COPOLYMER COATING SENSITIVE TO IONIC STRENGTH | Revolymer Limited (GB) | 2014-02-19 | — | — | EP | disclosed |
| US-20100144579-A1 | Color-Safe Detergent or Cleaning Agent having Optical Brightener | HENKEL AG & CO. KGAA (DE) | 2010-06-10 | — | — | US | disclosed |
| US-20100081603-A1 | BLEACH-CONTAINING DETERGENT OR CLEANING AGENT | HENKEL AG & CO. KGAA (DE) | 2010-04-01 | — | — | US | disclosed |
| US-20090075856-A1 | Encapsulated Bleaching Agent Particles | HENKEL AG & CO. KGAA (DE) | 2009-03-19 | — | — | US | disclosed |
| US-20070117735-A1 | Liquid detergent or cleansing composition containing a water-soluble, encapsulated bleaching agent | HENKEL AG & CO. KGAA (DE) | 2007-05-24 | — | — | US | disclosed |
| US-20070093402-A1 | Bleaching agent particles encapsulated in a water soluble material | HENKEL AG & CO. KGAA (DE) | 2007-04-26 | — | — | US | disclosed |
| US-20050227896-A1 | Multicomponent liquid detergent | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) | 2005-10-13 | — | — | US | disclosed |
| EP-0711277-A1 | AMIDO PEROXYCARBOXYLIC ACIDS FOR BLEACHING | UNILEVER PLC (GB) | 1996-05-15 | — | — | EP | disclosed |
| WO-1995003276-A1 | AMIDO PEROXYCARBOXYLIC ACIDS FOR BLEACHING | UNILEVER N.V. (NL) | 1995-02-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140171327-A1 | NOVEL COMPOSITE | PUF60, C5, VCL | PPARG 4783/4885ALDH1A1 3641/4885CYP1A2 3685/4885 |
| US-10093621-B2 | 4-oxo-N-(4-hydroxyphenyl)retinamide derivatives as therapeutic agents for the treatment of cancer | ALDH1A2, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RB1 | PPARG 4315/4885ALDH1A1 152/4885CYP1A2 2936/4885 |
| US-20170253560-A1 | 4-OXO-N-(4-HYDROXYPHENYL)RETINAMIDE DERIVATIVES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF CANCER | ALDH1A2, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RB1 | PPARG 4315/4885ALDH1A1 152/4885CYP1A2 2936/4885 |
| US-20140171328-A1 | NOVEL COMPOSITE | VMA21, PUF60, PLA2G2C | PPARG 4661/4885ALDH1A1 3425/4885CYP1A2 3646/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.